Research ArticleClinical Studies
Oxaliplatin, Irinotecan and Cetuximab in Advanced Gastric Cancer. A Multicenter Phase II Trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)
EWALD WÖLL, RICHARD GREIL, WOLFGANG EISTERER, OLIVER BECHTER, MICHAEL A. FRIDRIK, BIRGIT GRÜNBERGER, AUGUST ZABERNIGG, BEATE MAYRBÄURL, GUDRUN RUSS, MARGIT DLASKA, PETER OBRIST and JOSEF THALER
Anticancer Research December 2011, 31 (12) 4439-4443;
EWALD WÖLL
RICHARD GREIL
WOLFGANG EISTERER
OLIVER BECHTER
MICHAEL A. FRIDRIK
BIRGIT GRÜNBERGER
AUGUST ZABERNIGG
BEATE MAYRBÄURL
GUDRUN RUSS
MARGIT DLASKA
PETER OBRIST
In this issue
Anticancer Research
Vol. 31, Issue 12
December 2011
Oxaliplatin, Irinotecan and Cetuximab in Advanced Gastric Cancer. A Multicenter Phase II Trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)
EWALD WÖLL, RICHARD GREIL, WOLFGANG EISTERER, OLIVER BECHTER, MICHAEL A. FRIDRIK, BIRGIT GRÜNBERGER, AUGUST ZABERNIGG, BEATE MAYRBÄURL, GUDRUN RUSS, MARGIT DLASKA, PETER OBRIST, JOSEF THALER
Anticancer Research Dec 2011, 31 (12) 4439-4443;
Oxaliplatin, Irinotecan and Cetuximab in Advanced Gastric Cancer. A Multicenter Phase II Trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentöse Tumortherapie (AGMT)
EWALD WÖLL, RICHARD GREIL, WOLFGANG EISTERER, OLIVER BECHTER, MICHAEL A. FRIDRIK, BIRGIT GRÜNBERGER, AUGUST ZABERNIGG, BEATE MAYRBÄURL, GUDRUN RUSS, MARGIT DLASKA, PETER OBRIST, JOSEF THALER
Anticancer Research Dec 2011, 31 (12) 4439-4443;
Jump to section
Related Articles
- No related articles found.